AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Erica Jefferson

Office of Public Affairs, U.S. Food and Drug Administration 

FDA Advises Patients and Care Providers on Drug Combination Safety Considerations

FDA

The U.S. Food and Drug Administration (FDA) is committed to keeping the public updated on advances and shifts in treatment options and methods. The FDA is reviewing data that suggest use of the HIV drug Invirase (saquinavir) in combination with Norvir (ritonavir) may have a potentially serious effect on a patient’s heart. The data, drawn…